Anti-SARS-CoV-2 in vitro potential of castor oil plant (Ricinus communis) leaf extract: in-silico virtual evidence.

The study found that a methylene chloride extract from the medicinal plant L. had strong antiviral activity against SARS-CoV-2, while specific compounds in the plant showed potent activity against MERS and SARS-CoV-2. Further research is needed to fully understand their potential as natural antivirals.

Elkousy RH et al (2023).

Z Naturforsch C J Biosci.

DOI:

10.1515/znc-2023-0075

PubMed:

37401758

The effect of Aromatherapy with Pelargonium graveolens (P. graveolens) on the fatigue and sleep quality of critical care nurses during the Covid-19 pandemic: A randomized controlled trial.

Aromatherapy with Pelargonium graveolens essential oil reduces fatigue and improves sleep quality for ICU nurses, benefitting patient care and nurse well-being.

Karimi N et al (2023).

Explore (NY).

DOI:

10.1016/j.explore.2023.06.006

PubMed:

37400355

The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.

Bitter melon proteins can inhibit SARS-CoV-2 replication and have potential for COVID-19 treatment, according to new research. Two specific proteins from bitter melon, MAP30 and Momordin, showed strong inhibition of the virus in lung cells without damaging the cells. This discovery could lead to the development of effective treatments for COVID-19.

Watts NR et al (2023).

PLoS One.

DOI:

10.1371/journal.pone.0286370

PubMed:

37384752

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2.

This study explores the antiviral potential of Chinese mugwort, Artemisia argyi, against SARS-CoV-2, highlighting its historical use and antimicrobial properties.

Cheng FJ et al (2023).

Cell Biosci.

DOI:

10.1186/s13578-023-01070-y

PubMed:

37381062

The potential of Panax notoginseng against COVID-19 infection.

Hu Y et al (2023).

J Ginseng Res.

DOI:

10.1016/j.jgr.2023.04.002

PubMed:

37362082

Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials.

Review finds that plant-based drugs, particularly herbs, used as add-on therapy for COVID-19 show efficacy and safety, potentially enhancing the immune system for treating the virus. (37 words)

Diantini A, Febriyanti RM and Levita J (2023).

Infect Drug Resist.

DOI:

10.2147/IDR.S417727

PubMed:

37361940

Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking.

A study found that a pigment-depleted extract from the heartwood of L. f. contains compounds with potential anti-SARS-CoV-2 activity. This discovery emphasizes the significance of advanced analytical methods in identifying treatments and understanding natural compounds' therapeutic abilities.

Wasilewicz A et al (2023).

Front Mol Biosci.

DOI:

10.3389/fmolb.2023.1202394

PubMed:

37347040

Promising roles of Zingiber officinale roscoe, Curcuma longa L., and Momordica charantia L. as immunity modulators against COVID-19: A bibliometric analysis.

Study examines therapeutic potential of antioxidant, anti-inflammatory, immune-stimulating plants against SARS-CoV-2. India leads research, proposes herbal blend for COVID-19 treatment and prevention.

Sheikh HI et al (2023).

J Agric Food Res.

DOI:

10.1016/j.jafr.2023.100680

PubMed:

37346755